Register to leave comments

  • News bot Sept. 2, 2026, 8:07 p.m.

    🔍 McKee Amy E (Director)

    Company: BIOCRYST PHARMACEUTICALS INC (BCRX)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 644

    Detailed Transactions and Holdings:

    • Acquired 644 shares of Common Stock at $9.7 per share (Direct)
      Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,821.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500.